YMTX Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-04-26 | 2023 | Craig W. Philips President | 362,729 | 0 | 0 | 0 | 0 | 993,404 |
| 2024-04-26 | 2022 | Craig W. Philips President | 290,671 | 95,000 | 0 | 0 | 0 | 1,186,161 |
| 2024-04-26 | 2022 | Keith A. Baker Chief Financial Officer | 57,692 | 0 | 0 | 0 | 0 | 537,896 |
| 2024-04-26 | 2022 | Keith A. Baker Chief Financial Officer | 57,692 | 0 | 0 | 0 | 0 | 537,896 |
| 2024-04-26 | 2023 | Keith A. Baker Chief Financial Officer | 332,692 | 0 | 0 | 0 | 0 | 813,692 |
| 2024-04-26 | 2023 | Keith A. Baker Chief Financial Officer | 332,692 | 0 | 0 | 0 | 0 | 813,692 |
| 2024-04-26 | 2022 | Craig W. Philips President | 290,671 | 95,000 | 0 | 0 | 0 | 1,186,161 |
| 2024-04-26 | 2023 | Shawn Iadonato, Ph.D. Chief Executive Officer and Director | 448,077 | 0 | 0 | 0 | 0 | 1,283,646 |
| 2024-04-26 | 2022 | Shawn Iadonato, Ph.D. Chief Executive Officer and Director | 350,002 | 140,000 | 0 | 0 | 0 | 1,608,712 |
| 2024-04-26 | 2022 | Shawn Iadonato, Ph.D. Chief Executive Officer and Director | 350,002 | 140,000 | 0 | 0 | 0 | 1,608,712 |
| 2024-04-26 | 2023 | Craig W. Philips President | 362,729 | 0 | 0 | 0 | 0 | 993,404 |
| 2024-04-26 | 2023 | Shawn Iadonato, Ph.D. Chief Executive Officer and Director | 448,077 | 0 | 0 | 0 | 0 | 1,283,646 |
| 2023-04-28 | 2022 | Richard Peters M.D.Ph.D. Former Chief Executive Officer | 594,626 | 296,727 | 0 | 0 | 0 | 3,211,587 |
| 2023-04-28 | 2022 | Craig W. Philips President | 290,671 | 95,000 | 0 | 0 | 0 | 1,186,161 |
| 2023-04-28 | 2022 | Craig W. Philips President | 290,671 | 95,000 | 0 | 0 | 0 | 1,186,161 |
| 2023-04-28 | 2021 | Shawn Iadonato Ph.D., Chief Executive Officer and Director | 234,619 | 273,750 | 0 | 0 | 0 | 1,657,437 |
| 2023-04-28 | 2021 | Shawn Iadonato Ph.D., Chief Executive Officer and Director | 234,619 | 273,750 | 0 | 0 | 0 | 1,657,437 |
| 2023-04-28 | 2022 | Shawn Iadonato Ph.D., Chief Executive Officer and Director | 350,002 | 140,000 | 0 | 0 | 0 | 1,608,712 |
| 2023-04-28 | 2022 | Shawn Iadonato Ph.D., Chief Executive Officer and Director | 350,002 | 140,000 | 0 | 0 | 0 | 1,608,712 |
| 2023-04-28 | 2022 | Michael Wyzga Former Senior Vice President and Chief Financial Officer | 336,762 | 134,247 | 0 | 0 | 0 | 837,493 |
| 2023-04-28 | 2021 | Devin Smith J.D. Former Senior Vice President, General Counsel and Secretary | 192,235 | 22,000 | 0 | 0 | 0 | 1,034,544 |
| 2023-04-28 | 2021 | Devin Smith J.D. Former Senior Vice President, General Counsel and Secretary | 192,235 | 22,000 | 0 | 0 | 0 | 1,034,544 |
| 2023-04-28 | 2022 | Devin Smith J.D. Former Senior Vice President, General Counsel and Secretary | 336,762 | 134,247 | 0 | 0 | 0 | 878,967 |
| 2023-04-28 | 2022 | Devin Smith J.D. Former Senior Vice President, General Counsel and Secretary | 336,762 | 134,247 | 0 | 0 | 0 | 878,967 |
| 2023-04-28 | 2021 | Richard Peters M.D.Ph.D. Former Chief Executive Officer | 618,000 | 0 | 0 | 0 | 0 | 4,494,855 |
| 2023-04-28 | 2021 | Richard Peters M.D.Ph.D. Former Chief Executive Officer | 618,000 | 0 | 0 | 0 | 0 | 4,494,855 |
| 2023-04-28 | 2022 | Richard Peters M.D.Ph.D. Former Chief Executive Officer | 594,626 | 296,727 | 0 | 0 | 0 | 3,211,587 |
| 2023-04-28 | 2021 | Pauline Kenny General Counsel | 217,360 | 15,750 | 0 | 0 | 0 | 473,011 |
| 2023-04-28 | 2021 | Pauline Kenny General Counsel | 217,360 | 15,750 | 0 | 0 | 0 | 473,011 |
| 2023-04-28 | 2022 | Pauline Kenny General Counsel | 224,132 | 65,000 | 0 | 0 | 0 | 741,732 |
| 2023-04-28 | 2022 | Pauline Kenny General Counsel | 224,132 | 65,000 | 0 | 0 | 0 | 741,732 |
| 2023-04-28 | 2021 | Craig W. Philips President | 196,931 | 188,000 | 0 | 0 | 0 | 2,613,483 |
| 2023-04-28 | 2021 | Craig W. Philips President | 196,931 | 188,000 | 0 | 0 | 0 | 2,613,483 |
| 2023-04-28 | 2021 | Michael Wyzga Former Senior Vice President and Chief Financial Officer | 131,250 | 0 | 0 | 0 | 0 | 681,704 |
| 2023-04-28 | 2021 | Michael Wyzga Former Senior Vice President and Chief Financial Officer | 131,250 | 0 | 0 | 0 | 0 | 681,704 |
| 2023-04-28 | 2022 | Michael Wyzga Former Senior Vice President and Chief Financial Officer | 336,762 | 134,247 | 0 | 0 | 0 | 837,493 |
| 2022-04-25 | 2020 | N. Anthony Coles, M.D. Chair of the Board of Directors, and former Executive Chair | 390,000 | 0 | 0 | 312,000 | 0 | 744,046 |
| 2022-04-25 | 2020 | N. Anthony Coles, M.D. Chair of the Board of Directors, and former Executive Chair | 390,000 | 0 | 0 | 312,000 | 0 | 744,046 |
| 2022-04-25 | 2021 | N. Anthony Coles, M.D. Chair of the Board of Directors, and former Executive Chair | 170,418 | 0 | 20,001 | 75,733 | 173,333 | 1,532,259 |
| 2022-04-25 | 2021 | N. Anthony Coles, M.D. Chair of the Board of Directors, and former Executive Chair | 170,418 | 0 | 20,001 | 75,733 | 173,333 | 1,532,259 |
| 2022-04-25 | 2021 | Ajay Verma, M.D., Ph.D. Former Executive Vice President, Head of Research & Development | 309,469 | 0 | 114,900 | 108,647 | 0 | 1,826,573 |
| 2022-04-25 | 2021 | Ajay Verma, M.D., Ph.D. Former Executive Vice President, Head of Research & Development | 309,469 | 0 | 114,900 | 108,647 | 0 | 1,826,573 |
| 2022-04-25 | 2020 | Paulash Mohsen Former Chief Business Officer | 374,764 | 0 | 0 | 205,000 | 1,733 | 733,221 |
| 2022-04-25 | 2020 | Richard Peters, M.D., Ph.D. Chief Executive Officer | 600,000 | 0 | 0 | 480,000 | 1,956 | 1,320,695 |
| 2022-04-25 | 2021 | Paulash Mohsen Former Chief Business Officer | 400,000 | 0 | 160,057 | 147,200 | 0 | 1,172,630 |
| 2022-04-25 | 2021 | Richard Peters, M.D., Ph.D. Chief Executive Officer | 618,000 | 0 | 1,358,370 | 278,100 | 0 | 4,494,240 |
| 2022-04-25 | 2021 | Paulash Mohsen Former Chief Business Officer | 400,000 | 0 | 160,057 | 147,200 | 0 | 1,172,630 |
| 2022-04-25 | 2020 | Paulash Mohsen Former Chief Business Officer | 374,764 | 0 | 0 | 205,000 | 1,733 | 733,221 |
| 2022-04-25 | 2021 | Richard Peters, M.D., Ph.D. Chief Executive Officer | 618,000 | 0 | 1,358,370 | 278,100 | 0 | 4,494,240 |
| 2022-04-25 | 2020 | Richard Peters, M.D., Ph.D. Chief Executive Officer | 600,000 | 0 | 0 | 480,000 | 1,956 | 1,320,695 |
| 2021-04-22 | 2020 | Richard Peters, M.D., Ph.D. Chief Executive Officer | 600,000 | 0 | 0 | 480,000 | 1,956 | 1,320,695 |
| 2021-04-22 | 2019 | Richard Peters, M.D., Ph.D. Chief Executive Officer | 195,769 | 0 | 0 | 83,312 | 1,965 | 3,818,022 |
| 2021-04-22 | 2020 | Paulash Mohsen Chief Business Officer | 374,764 | 0 | 0 | 205,000 | 1,733 | 733,221 |
| 2021-04-22 | 2020 | Paulash Mohsen Chief Business Officer | 374,764 | 0 | 0 | 205,000 | 1,733 | 733,221 |
| 2021-04-22 | 2019 | Paulash Mohsen Chief Business Officer | 357,108 | 0 | 0 | 94,277 | 4,915 | 456,300 |
| 2021-04-22 | 2019 | Paulash Mohsen Chief Business Officer | 357,108 | 0 | 0 | 94,277 | 4,915 | 456,300 |
| 2021-04-22 | 2020 | Meenu Chhabra Former Chief Executive Officer | 560,043 | 0 | 267,288 | 0 | 857,902 | 3,268,410 |
| 2021-04-22 | 2020 | Meenu Chhabra Former Chief Executive Officer | 560,043 | 0 | 267,288 | 0 | 857,902 | 3,268,410 |
| 2021-04-22 | 2019 | Meenu Chhabra Former Chief Executive Officer | 539,600 | 0 | 0 | 296,780 | 8,400 | 1,980,721 |
| 2021-04-22 | 2019 | Meenu Chhabra Former Chief Executive Officer | 539,600 | 0 | 0 | 296,780 | 8,400 | 1,980,721 |
| 2021-04-22 | 2020 | Marija Zecevic Former Chief Commercial Officer | 377,790 | 0 | 145,898 | 0 | 390,565 | 1,420,065 |
| 2021-04-22 | 2020 | Marija Zecevic Former Chief Commercial Officer | 377,790 | 0 | 145,898 | 0 | 390,565 | 1,420,065 |
| 2021-04-22 | 2019 | Sheila Wilson Former Chief Operating Officer | 358,100 | 0 | 0 | 157,564 | 6,300 | 946,851 |
| 2021-04-22 | 2019 | Sheila Wilson Former Chief Operating Officer | 358,100 | 0 | 0 | 157,564 | 6,300 | 946,851 |
| 2021-04-22 | 2020 | Sheila Wilson Former Chief Operating Officer | 237,172 | 0 | 0 | 0 | 388,224 | 784,144 |
| 2021-04-22 | 2020 | Sheila Wilson Former Chief Operating Officer | 237,172 | 0 | 0 | 0 | 388,224 | 784,144 |
| 2021-04-22 | 2019 | Marija Zecevic Former Chief Commercial Officer | 364,000 | 0 | 0 | 160,160 | 6,300 | 955,307 |
| 2021-04-22 | 2019 | Marija Zecevic Former Chief Commercial Officer | 364,000 | 0 | 0 | 160,160 | 6,300 | 955,307 |
| 2021-04-22 | 2020 | N. Anthony Coles Executive Chair of the Board of Directors | 390,000 | 0 | 0 | 312,000 | 0 | 744,046 |
| 2021-04-22 | 2020 | N. Anthony Coles Executive Chair of the Board of Directors | 390,000 | 0 | 0 | 312,000 | 0 | 744,046 |
| 2021-04-22 | 2019 | N. Anthony Coles Executive Chair of the Board of Directors | 469,211 | 0 | 0 | 170,703 | 0 | 931,289 |
| 2021-04-22 | 2019 | N. Anthony Coles Executive Chair of the Board of Directors | 469,211 | 0 | 0 | 170,703 | 0 | 931,289 |
| 2021-04-22 | 2020 | Richard Peters, M.D., Ph.D. Chief Executive Officer | 600,000 | 0 | 0 | 480,000 | 1,956 | 1,320,695 |
| 2021-04-22 | 2019 | Richard Peters, M.D., Ph.D. Chief Executive Officer | 195,769 | 0 | 0 | 83,312 | 1,965 | 3,818,022 |
| 2020-04-29 | 2019 | Sheila Wilson | 358,100 | 0 | 0 | 157,564 | 6,300 | 946,851 |
| 2020-04-29 | 2019 | Meenu Chhabra President, and Chief Executive Officer | 539,600 | 0 | 0 | 296,780 | 8,400 | 1,980,721 |
| 2020-04-29 | 2019 | Meenu Chhabra President, and Chief Executive Officer | 539,600 | 0 | 0 | 296,780 | 8,400 | 1,980,721 |
| 2020-04-29 | 2018 | Meenu Chhabra President, and Chief Executive Officer | 515,000 | 0 | 0 | 257,500 | 0 | 1,783,730 |
| 2020-04-29 | 2018 | Meenu Chhabra President, and Chief Executive Officer | 515,000 | 0 | 0 | 257,500 | 0 | 1,783,730 |
| 2020-04-29 | 2019 | Sheila Wilson | 358,100 | 0 | 0 | 157,564 | 6,300 | 946,851 |
| 2020-04-29 | 2019 | Marija Zecevic, Ph.D. | 364,000 | 0 | 0 | 160,160 | 6,300 | 955,307 |
| 2020-04-29 | 2019 | Marija Zecevic, Ph.D. | 364,000 | 0 | 0 | 160,160 | 6,300 | 955,307 |
| 2020-04-29 | 2019 | Po-Shun Lee, M.D. Former Executive Vice President and Chief Medical Officer | 225,705 | 0 | 0 | 80,245 | 239,903 | 987,331 |
| 2020-04-29 | 2019 | Po-Shun Lee, M.D. Former Executive Vice President and Chief Medical Officer | 225,705 | 0 | 0 | 80,245 | 239,903 | 987,331 |
| 2020-04-29 | 2018 | Po-Shun Lee, M.D. Former Executive Vice President and Chief Medical Officer | 360,706 | 0 | 0 | 126,247 | 0 | 783,070 |
| 2020-04-29 | 2018 | Po-Shun Lee, M.D. Former Executive Vice President and Chief Medical Officer | 360,706 | 0 | 0 | 126,247 | 0 | 783,070 |
| 2019-04-30 | 2017 | Benito Munoz, M.Sc., Ph.D. Chief Scientific Officer | 335,500 | 79,850 | 0 | 0 | 0 | 715,084 |
| 2019-04-30 | 2017 | Benito Munoz, M.Sc., Ph.D. Chief Scientific Officer | 335,500 | 79,850 | 0 | 0 | 0 | 715,084 |
| 2019-04-30 | 2018 | Benito Munoz, M.Sc., Ph.D. Chief Scientific Officer | 349,040 | 128,228 | 0 | 0 | 0 | 646,682 |
| 2019-04-30 | 2018 | Benito Munoz, M.Sc., Ph.D. Chief Scientific Officer | 349,040 | 128,228 | 0 | 0 | 0 | 646,682 |
| 2019-04-30 | 2017 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 350,201 | 83,347 | 0 | 0 | 0 | 783,070 |
| 2019-04-30 | 2017 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 350,201 | 83,347 | 0 | 0 | 0 | 783,070 |
| 2019-04-30 | 2018 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 360,706 | 126,247 | 0 | 0 | 0 | 647,768 |
| 2019-04-30 | 2018 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 360,706 | 126,247 | 0 | 0 | 0 | 647,768 |
| 2019-04-30 | 2017 | Meenu Chhabra President and Chief Executive Officer | 500,000 | 150,000 | 0 | 0 | 0 | 1,783,730 |
| 2019-04-30 | 2017 | Meenu Chhabra President and Chief Executive Officer | 500,000 | 150,000 | 0 | 0 | 0 | 1,783,730 |
| 2019-04-30 | 2018 | Meenu Chhabra President and Chief Executive Officer | 515,000 | 257,500 | 0 | 0 | 0 | 1,289,270 |
| 2019-04-30 | 2018 | Meenu Chhabra President and Chief Executive Officer | 515,000 | 257,500 | 0 | 0 | 0 | 1,289,270 |
| 2018-04-19 | 2017 | Meenu Chhabra President, and Chief Executive Officer | 500,000 | 150,000 | 0 | 0 | 0 | 1,783,730 |
| 2018-04-19 | 2017 | Benito Munoz, M.Sc., Ph.D. | 335,500 | 79,850 | 0 | 0 | 0 | 715,084 |
| 2018-04-19 | 2017 | Benito Munoz, M.Sc., Ph.D. | 335,500 | 79,850 | 0 | 0 | 0 | 715,084 |
| 2018-04-19 | 2016 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 334,892 | 119,000 | 0 | 0 | 0 | 979,757 |
| 2018-04-19 | 2016 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 334,892 | 119,000 | 0 | 0 | 0 | 979,757 |
| 2018-04-19 | 2017 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 350,201 | 83,347 | 0 | 0 | 0 | 783,070 |
| 2018-04-19 | 2017 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 350,201 | 83,347 | 0 | 0 | 0 | 783,070 |
| 2018-04-19 | 2016 | Meenu Chhabra President, and Chief Executive Officer | 450,138 | 232,500 | 0 | 0 | 0 | 1,539,701 |
| 2018-04-19 | 2016 | Meenu Chhabra President, and Chief Executive Officer | 450,138 | 232,500 | 0 | 0 | 0 | 1,539,701 |
| 2018-04-19 | 2017 | Meenu Chhabra President, and Chief Executive Officer | 500,000 | 150,000 | 0 | 0 | 0 | 1,783,730 |
| 2017-04-27 | 2016 | Meenu Chhabra President, and Chief Executive Officer | 450,138 | 232,500 | 0 | 0 | 0 | 1,539,701 |
| 2017-04-27 | 2016 | James DeTore | 125,000 | 0 | 0 | 0 | 0 | 1,018,832 |
| 2017-04-27 | 2016 | James DeTore | 125,000 | 0 | 0 | 0 | 0 | 1,018,832 |
| 2017-04-27 | 2015 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 285,010 | 103,545 | 0 | 0 | 0 | 703,463 |
| 2017-04-27 | 2015 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 285,010 | 103,545 | 0 | 0 | 0 | 703,463 |
| 2017-04-27 | 2016 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 334,892 | 119,000 | 0 | 0 | 0 | 979,757 |
| 2017-04-27 | 2016 | Po-Shun Lee, M.D. Executive Vice President and Chief Medical Officer | 334,892 | 119,000 | 0 | 0 | 0 | 979,757 |
| 2017-04-27 | 2015 | Meenu Chhabra President, and Chief Executive Officer | 432,285 | 261,313 | 0 | 0 | 10,200 | 1,585,665 |
| 2017-04-27 | 2015 | Meenu Chhabra President, and Chief Executive Officer | 432,285 | 261,313 | 0 | 0 | 10,200 | 1,585,665 |
| 2017-04-27 | 2016 | Meenu Chhabra President, and Chief Executive Officer | 450,138 | 232,500 | 0 | 0 | 0 | 1,539,701 |
| 2016-04-29 | 2014 | Janet L. Smart, Ph.D., J.D. Vice President, Intellectual Property and Legal Affairs | 204,111 | 39,778 | 0 | 0 | 0 | 255,925 |
| 2016-04-29 | 2014 | Janet L. Smart, Ph.D., J.D. Vice President, Intellectual Property and Legal Affairs | 204,111 | 39,778 | 0 | 0 | 0 | 255,925 |
| 2016-04-29 | 2015 | Janet L. Smart, Ph.D., J.D. Vice President, Intellectual Property and Legal Affairs | 209,641 | 37,126 | 0 | 0 | 0 | 319,421 |
| 2016-04-29 | 2015 | Janet L. Smart, Ph.D., J.D. Vice President, Intellectual Property and Legal Affairs | 209,641 | 37,126 | 0 | 0 | 0 | 319,421 |
| 2016-04-29 | 2015 | Po-Shun Lee, M.D. | 285,010 | 103,545 | 0 | 0 | 0 | 703,253 |
| 2016-04-29 | 2015 | Po-Shun Lee, M.D. | 285,010 | 103,545 | 0 | 0 | 0 | 703,253 |
| 2016-04-29 | 2014 | Meenu Chhabra President, and Chief Executive Officer | 253,365 | 105,260 | 0 | 0 | 3,000 | 1,048,260 |
| 2016-04-29 | 2014 | Meenu Chhabra President, and Chief Executive Officer | 253,365 | 105,260 | 0 | 0 | 3,000 | 1,048,260 |
| 2016-04-29 | 2015 | Meenu Chhabra President, and Chief Executive Officer | 432,285 | 261,313 | 0 | 0 | 10,200 | 1,585,665 |
| 2016-04-29 | 2015 | Meenu Chhabra President, and Chief Executive Officer | 432,285 | 261,313 | 0 | 0 | 10,200 | 1,585,665 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
